Metabolic Health

Ultra-Processed Foods Linked to Poorer Focus and Memory

New research links higher ultra-processed food intake to weaker attention and rising dementia risk, even when overall diet quality is decent.

Survodutide cut weight 16.6% and liver fat 63% in Phase 3 trials while sparing lean mass. Here’s what the new dual GLP-1/glucagon drug does.

New research suggests GLP-1 drugs like Ozempic may slow biological aging markers. Here’s what the science shows and where it falls short.

Research suggests eating avocado daily may improve blood sugar control. Learn what the science says about avocados, insulin, and metabolic health.

New Lancet research shows ultra-processed plant-based foods raise heart disease risk 5% and CVD mortality 12% — vegan isn’t automatically healthy.

New research links GLP-1 drugs like Ozempic and Wegovy to a 30% lower breast cancer risk in women with obesity. What the data shows.

GLP-1 drugs like Ozempic cause up to 40% of weight loss to come from lean mass. Here’s what research says about protecting muscle and bone.

New trials suggest lower-dose GLP-1 drugs can maintain weight loss after high-dose treatment, easing side effects and long-term costs.

Discovered 30 years ago, leptin is back in weight loss science. Research suggests new uses for the ‘satiety hormone’ in obesity care.